Global Conference Coverage: Application and Implications of High-Impact Data From the European Hematology Association Congress 2022 *

June 9-17, 2022; Vienna, Austria
Learn from international experts how key studies presented at the 2022 EHA annual meeting will affect management of patients with hematologic malignancies in this online program and accompanying highlights downloadable slideset.

Share

Program Content

Activities

EHA 2022 Congress Highlights
Global Conference Coverage: Application and Implications of High-Impact Data From the European Hematology Association Congress 2022
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2022

Expires: June 29, 2023

Activities

EHA 2022: Key Studies
An Expert’s Guide to EHA 2022: A Preview of the Top Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2022

Expires: June 19, 2023

Activities

EHA 2022 Highlights
CCO Independent Conference Highlights of the European Hematology Association 2022 Congress
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 06, 2022

Expires: September 05, 2023

Faculty

cover img faculity

Stéphane de Botton, MD

Associate Professor
Department of Clinical Hematology
Université Paris Saclay
Paris, France
Physician
Department of Hematology
Gustave Roussy
Villejuif, France

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

cover img faculity

Alessandra Tedeschi, MD

Director of Indolent Lymphoproliferative Disorders
Department of Hematology
Niguarda Cancer Center
Niguarda Hospital
Milan, Italy

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene Ltd

Jazz Pharmaceuticals Inc

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.